Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer
Tamara L. Lotan, Harsimar B. Kaur, Daniela C. Salles, Sanjana Murali, Edward M. Schaeffer, Jerry S. Lanchbury, William B. Isaacs, Robert Brown, Andrea L. Richardson, Olivier Cussenot, Geraldine Cancel-Tassin, Kirsten M. Timms, Emmanuel S. Antonarakis
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer'. Together they form a unique fingerprint.